Fact Sheets on Antiretroviral Drugs

ACKNOWLEDGEMENTS
This document was prepared by Dr Emanuele Pontali, Associate Professional Officer,
HSI-STB unit, WHO Regional Office for South-East Asia. It was reviewed and
modified during the “Informal Consultation on Use of Antiretrovirals in Asia”, New
Delhi, 7-9 May 2002. The following experts participated in the consultation: Dr
Anupong Chitwarakorn, Senior Expert in Preventive Medicine, Department of
Communicable Disease Control, Ministry of Public Health, Bangkok, Thailand; Dr
Chris Duncombe, Senior Consultant, HIV-NAT, Thai Red Cross AIDS Research
Centre, Bangkok, Thailand; Dr Subhash Hira, Director, AIDS Research and Control
Centre (ARCON), Sir J J Hospital, Mumbai, India; Dr Htin Aung Saw, Consultant
Physician, Specialist Hospital, Waibargi, Yangon, Myanmar; Prof Taimor Nawaz,
Director, Medical Education Centre, Bangladesh Medical College, Dhaka,
Bangladesh; Dr D Sengupta, Consultant, National AIDS Control Organization
(NACO), New Delhi, India; Prof S K Sharma, Professor, Department of Medicine, All
India Institute of Medical Sciences (AIIMS), New Delhi, India; Dr Broto Wasisto,
Special Adviser, Ministry of Health, Jakarta, Indonesia; Dr Basil Vareldzis, Medical
Officer, ARV Drugs, Department of HIV/AIDS, WHO Headquarters, Geneva,
Switzerland; Dr Ying-Ru Lo, Medical Officer (HIV/AIDS), WHO Country Office,
Bangkok, Thailand; Dr D C S Reddy, National Programme Officer (HIV/AIDS), WHO
Country Office, New Delhi, India; and Dr N Kumara Rai, Director, Department of
Communicable Diseases; Dr K Weerasuriya, Regional Adviser-Essential Drugs and
Medicines Policy; Dr Jai P Narain, Regional Adviser, HIV/STI Initiative and Stop
Tuberculosis; and Dr Nani Nair, Short-term Professional (TB) of the WHO/SEARO,
New Delhi, India.
The following individuals reviewed the draft text and provided helpful
comments and suggestions: Dr Purushottam N Shrestha, ex-Regional Adviser
(HIV/AIDS), WHO-EMRO, Alexandria, Egypt; Dr Valentina Dias-Ferrao, independent
Health Consultant, Germany; Dr Valerio Del Bono, Senior Consultant in Infectious
Diseases, Infectious Diseases Department, University of Genoa, Italy, and Dr Federica
Toscanini, Consultant in Infectious Diseases, Health Service for HIV infection, Prison
of Genoa, Italy.
Comments and requests for more information may be directed to HSI-STB Unit,
World Health Organization, Regional Office for South-East Asia, World Health House,
I.P. Estate, Mahatma Gandhi Road, New Delhi-110002, India.
Page iii